TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Unimedic Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
386,076
|
298,436
|
242,097 |
Financial expenses |
3,847
|
2,016
|
1,052 |
Earnings before taxes |
74,119
|
63,890
|
29,424 |
EBITDA |
83,907
|
72,518
|
36,603 |
Total assets |
202,017
|
188,039
|
133,175 |
Current assets |
186,801
|
167,244
|
110,156 |
Current liabilities |
58,254
|
80,421
|
59,316 |
Equity capital |
76,673
|
34,876
|
19,717 |
- share capital |
203
|
189
|
195 |
Employees (average) |
27
![]() |
27
|
25 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
38.0%
|
18.5%
|
14.8% |
Turnover per employee |
14,299
|
11,053
|
9,684 |
Profit as a percentage of turnover |
19.2%
|
21.4%
|
12.2% |
Return on assets (ROA) |
38.6%
|
35.0%
|
22.9% |
Current ratio |
320.7%
|
208.0%
|
185.7% |
Return on equity (ROE) |
96.7%
|
183.2%
|
149.2% |
Change turnover |
66,463
|
63,615
|
5,269 |
Change turnover % |
21%
|
27%
|
2% |
Chg. No. of employees |
0
|
2
![]() |
2 |
Chg. No. of employees % |
0%
|
8%
|
9% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.